Role of Myeloid Cell Factor-1 (Mcl-1) in Chronic Lymphocytic Leukemia

References

• Johnston, J.B. (1999) Chronic lymphocytic leukemia. In Wintrobe's Clinical Hematology, 10th Edition, edited by G.R. Lee, J. Foerster, J. Lukens, F. Paraskevas, G.R. Greer and G.M. Rodgers. Pp 2405 — 2427. Baltimore, MD: Williams and Wilkins.
   Google Scholar
• Cheson, B.D., Bennett, J.M., Greyer, M., Kay, N., Keating, M.J., O'Brien, S., et al. (1996) "National Cancer Institute—sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment", Blood, 87, 4990 — 4997.
   Google Scholar
• Caligaris-Cappio, F. and Hamblin, T.J. (1999) "B-cell chronic lymphocytic leukemia: a bird of a different feather", Journal of Clinical Oncology, 17, 399–408.
   PubMed Web of Science ®Google Scholar
• Rosenwald, A., Alizadeh, A.A., Widhopf, G., Simon, R., Davis, R.E., Yu, X., et al. (2001) "Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lympho-cytic leukemia", Journal of Experimental Medicine, 194, 1639 — 1646.
   Web of Science ®Google Scholar
• Oscier, D.G., Gardiner, A.C., Mould, Si., Glide, S., Davis, Z.A., Ibbotson, R.E., et al. (2002) "Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors", Blood, 100, 1177–1184.
   Google Scholar
• Ki5ber, A., Seiler, T., Benner, A., Bullinger, L., Brackle, E., Lichter, P., et al. (2002) "VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leuke-mia", Blood, 100, 1410— 1416.
   Google Scholar
• Rai, J.L., Sawitsky, A., Cronlcite, E.P., Chanana, A.D., Levy, R.N. and Pasternack, B.S. (1975) "Clinical staging of chronic lympho-cytic leukemia", Blood, 46, 219–234.
   Google Scholar
• Molica, S. and Alberti, A. (1987) "Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia", Cancer, 60, 2712–2716.
   Google Scholar
• Dighiero, G. and Binet, J-L. (2000) "When and how to treat chronic lymphocytic leukemia", New England Journal of Medicine, 343, 1799 — 1801.
   PubMed Web of Science ®Google Scholar
• Rai, KR., Peterson, B.L., Appelbaum, FR., Kolitz, J., Elias, L., Shepherd, L., et al. (2000) "Fludarabine compared with chloram-bucil as primary therapy for chronic lymphocytic leukemia", New England Journal of Medicine, 343, 1750 — 1757.
   Web of Science ®Google Scholar
• Leporrier, M., Chevret, S., Cazin, B., Boudjerra, N., Feugier, P., Desablens, B., et al. for the French Cooperative Group on Chronic Lymphocytic Leukemia. (2001) "Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients", Blood, 98, 2319 — 2325.
   Google Scholar
• Hanada, M., Delia, D., Aiello, A., Stadtmauer, E. and Reed, J.C. (1993) "Bc1-2 gene hypomethylation and high-level expression inB-cell chronic lymphocytic leukemia", Blood, 82, 1820 —1828.
   Google Scholar
• Robertson, L.E., Plunkett, W., McConnell, K., Keating, M.J. and McDonnell, T.J. (1996) "Bc1-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome", Leukemia, 10, 456–459.
   PubMed Web of Science ®Google Scholar
• Christodoulopoulos, G., Fotouhi, N., Krajewski, S., Reed, J.C., Alaoui-Jamali, M. and Panasci, L. (1997) "Relationship between nitrogen mustard drug resistance in B-cell chronic lymphocytic leukemia (B-CLL) and protein expression of Bc1-2, Bax, Bcl-X and p53", Cancer Letters, 121, 59–67.
   PubMed Web of Science ®Google Scholar
• Johnston, J.B., Daeninck, P., Verburg, L., Lee, K., Williams, G., Israels, L.G., et al. (1997) "p53, mdmd-2, bax and bc1-2 and drug resistance in chronic lymphocytic leukemia", Leukemia and Lymphoma, 26, 435–449.
   PubMed Web of Science ®Google Scholar
• Pepper, C., Hoy, T. and Bentley, P. (1998) "Elevated Bc1-2/Bax are a consistent feature of apoptosis resistance in B-cell chronic leukaemia and are correlated with in vivo chemoresistance", Leukemia and Lymphoma, 28, 355–361.
   PubMed Web of Science ®Google Scholar
• Kitada, S., Anderson, J., Akar, S., Zapata, J.M., Takayama, S., Krajewslci, S., et al. (1998) "Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses", Blood, 91, 3379 — 3389.
   PubMed Web of Science ®Google Scholar
• Pepper, C., Thomas, A., Hoy, T., Cotter, F. and Bentley, P. (1999) "Antisense-mediated suppression of bc1-2 highlights its pivotal role in failed apoptosis in B-cell chronic lymphocytic leukaemia", British Journal of Haematology, 107, 611–615.
   PubMed Web of Science ®Google Scholar
• Hentgartner, M.O. (2000) "The biochemistry of apoptosis", Nature, 407, 770–776.
   Google Scholar
• Kroemer, G. (1997) "The proto-oncogene Bc1-2 and its role in regulating apoptosis", Nature Medicine, 3, 614 — 620.
   Google Scholar
• Craig, R.W. (2002) "MCLI provides a window on the role of the BCL2 family in cell proliferation, differentation and tumorigenesis", Leukemia, 16, 444–454.
   PubMed Web of Science ®Google Scholar
• Zhang, D., Li, F., Weidner, D., Mnjoyan, Z.H. and Fujise, K. (2002) "Physical and functional interaction between myeloid cell leukemia 1 protein (MCL I) and fortilin. The potential role of Mcll as a fortilin chaperone", Journal of Biological Chemistry, 277, 37430–37438.
   PubMed Web of Science ®Google Scholar
• Zhang, B., Gojo, I. and Fenton, R.G. (2002) "Myeloid cell factor-I is a critical survival factor for multiple myeloma", Blood, 99, 1885 — 1893.
   Web of Science ®Google Scholar
• Derenne, S., Monia, B., Dean, N.M., Taylor, J.K., Rapp, M.J., Harousseau, J.L., et al. (2002) "Antisense strategy show that Mc-1 rather than Bc1-2 or Bc1-XL is an essential survival protein of human myeloma cells", Blood, 100, 194 — 199.
   Google Scholar
• Moulding, D.A., Giles, R.V., Spiller, D.G., White, M.R.H., Tidd, D.M. and Edwards, SM. (2000) "Apoptosis is rapidly triggered by antisense depletion of MCL-I in differentiating U937 cells", Blood, 96, 1756–1763.
   Google Scholar
• Fujise, K., Zhang, D., Liu, J-1. and Yeh, E.T.H. (2000) "Regulation of apoptosis and cell cycle progression by MCL I. Differential role of proliferating cell nuclear antigen", Journal of Biological Chemistry, 275, 39458–39465.
   PubMed Web of Science ®Google Scholar
• Kozopas, KM., Yang, T., Buchan, H.L., Zhou, P. and Craig, R.W. (1993) "MCLI, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2", Proceedings of the National Academy USA, 90, 3516–3520.
   PubMed Web of Science ®Google Scholar
• Yang, T., Kozopas, K.M. and Craig, R.W. (1995) "The intracellular distribution and pattern of expression of Mc-1 overlap with, but are not identical to, those of Bc1-2", Journal of Cellular Biology, 128, 1173 — 1184.
   Google Scholar
• Yang, T., Buchan, H.L., Townsend, K.J. and Craig, R.W. J. (1996) "MCL-I, a member of the BCL-2 family, is induced rapidly in response to signals for cell differentiation or death, but not to signals for cell proliferation", Journal of Cellular Physiology, 166, 523–536.
   PubMed Web of Science ®Google Scholar
• Zhou, P., Levy, N.B., Xie, H., Qian, L., Lee, C.Y., Gascoyne, et al. (2001) "MCL 1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes", Blood, 97, 3902— 3909.
   Google Scholar
• Opferman, J.T., Letai, A., Beard, C., Sorcinelli, M.D., Ong, C.C. and Korsmeyer, Si. (2003) "Development and maintenance of B and T lymphocytes require antiapoptotic MCL- I", Nature, 426, 671–676.
   Google Scholar
• Pedersen, I.M., Kitada, S., Leoni, L.M., Zapata, J.M., Karras, J.G., Tsukada, N., et al. (2002) "Protection of CLL B cells by a follicular dendritic cell line dependent on induction of Mc1-1", Blood, 100, 1795— 1801.
   Google Scholar
• Bellosillo, B., Villamor, N., Colomer, D., Pons, G., Montserrat, E. and Gil, J. (1999) "In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia", Blood, 94, 2836–2843.
   Google Scholar
• Pérez-Galán, P., Marzo, I., Giraldo, P., Rubio-Félix, D., Lasierra, P., Larrad, L., et al. (2002) "Role of caspases and apoptosis-inducing factor (AIF) in cladribine-induced apoptosis of B cell chronic lymphocytic leukemia", Leukemia, 16, 2106–2114.
   Google Scholar
• Kitada, S., Zapata, J.M. Andrea'', M. and Reed, J.C. (2000) "Protein lcinase inhibitors flavopiridol and 7-hydroy-staurosporine down-regulate antiapoptosis proteins in B-cell chronic lymphocytic leukemia", Blood, 96, 393–397.
   PubMed Web of Science ®Google Scholar
• Pepper, C., Thomas, A., Hoy, T., Fegan, C. and Bentley, P. (2001) "Flavopiridol circumvents Bc1-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia", British Journal of Haematology, 114, 70–77.
   PubMed Web of Science ®Google Scholar
• Begleiter, A., Verburg, L., Ashique, A., Lee, K., Israels, L.G., Mowat, M.R.A., et al. (1995) "Comparison of antitumor activities of 2-chlorodeoxyadenosine and 9-/3-arabinosy1-2-fluoroadenine in chronic lymphocytic leukemia and marrow cells in vitro", Leuke-mia, 9, 1875–1881.
   Google Scholar
• Levesque, MC., O'Loughlin, C.W. and Weinberg, J.B. (2001) "Use of serum-free media to minimize apoptosis of chronic lympho-cytic leukemia cells during in vitro culture", Leukemia, 15, 1305–1307.
   PubMed Web of Science ®Google Scholar
• Gibson, EM., Henson, ES., Haney, N., Villanueva, J. and Gibson, S.B. (2002) "Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis by inhibiting cytochrome c release", Cancer Research, 62, 488–496.
   Google Scholar
• Van Stijn, A., van der Pol, MA., Feller, N., Roemen, G.M.J.M., Westra, A.H., Ossenkoppele, G.J., et al. (2003) "Multiparameter flow cytometric quantification of apoptosis-related protein expres-sion", Leukemia, 17, 787–788.
   Google Scholar
• Damle, RN., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., et al. (1999) "Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia", Blood, 94, 1840–1847.
   Web of Science ®Google Scholar
• Kaufmann, S.H., Karp, J.E., Svingen, P.A., Krajewslci, S., Burke, P.J., Gore, S.D., et al. (1998) "Elevated expression of the apoptotic regulator Mc-1 at the time of leukemic relapse", Blood, 91, 991 — 1000.
   Google Scholar
• Zhan, Q., Bieszczad, C.K., Bae, I., Fornace, A.J. Jr. and Craig, R.W. (1996) "Induction of BCL2 family member MCLI as an early response to DNA damage", Oncogene, 14, 1031— 1039.
   Google Scholar
• Jones, D.T., Ganeshaguru, K., Anderson, R.J., Jackson, T.R., Bruckdorfer, R., Low, S.Y., et al. (2003) "Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apopto-sis", Blood, 101, 3174–3180.
   Google Scholar
• Wang, J.-M., Chao, J.-R., Chen, W., Kuo, M.-L., Yen, J.J. and Yang,-Yen, H.-F. (1999) "The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-lcinase/Akt signaling path-way through a transcription factor complex containing CREB", Molecular and Cellular Biology, 19, 6195–6206.
   PubMed Web of Science ®Google Scholar
• Bae, J., Donigian, J.R. and Hsueh, A.J.W. (2003) "Tankyrase 1 interacts with Mc-1 proteins and inhibits their regulation of apoptosis", Journal of Biological Chemistry, 278, 5195–5204.
   PubMed Web of Science ®Google Scholar
• Zhang, B., Potyagaylo, V. and Fenton, R.G. (2003) "IL-6-independent expression of Mc-1 in human multiple myeloma", Oncogene, 22, 1848–1859.
   Web of Science ®Google Scholar
• Khoury, JD., Medeiros, Li., Rassidalcis, G.Z., McDonnell, T.J., Abruzzo, L.V. and Lai, R. (2003) "Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression", Journal of Pathology, 199, 90–97.
   PubMed Web of Science ®Google Scholar
• Krajewslci, S., Bodrug, S., Gascoyne, R., Berean, K., Krajewska, M. and Reed, J.C. (1994) "Immunohistochemical analysis of mcl-1 and bc1-2 proteins in normal and neoplastic lymph nodes", American Journal of Pathology, 145, 515— 525.
   Google Scholar
• Henson, ES., Gibson, EM., Villanueva, J., Bristow, N.A. and Gibson, S.B. (2003) "Increased expression of Mc-1 is responsible for the blockage of TRAIL-induced apoptosis mediated by EGF/ ErbB1 signaling pathway", Journal of Cellular Biochemistry, 89, 1177–1192.
   PubMed Web of Science ®Google Scholar
• Begleiter, A., Mowat, M., Israels, L.G. and Johnston, J.B. (1996) "Chlorambucil in chronic lymphocytic leukemia - mechanism of action", Leukemia and Lymphoma, 23, 187–201.
   PubMed Web of Science ®Google Scholar
• Genini, D., Adachi, S., Chao, Q., Rose, C.J., Carrera, H.B., Cottam, D.A., et al. (2000) "Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria", Blood, 96, 3537 — 3543.
   Google Scholar
• Pepper, C., Thomas, A., Hoy, T., Milligan, D., Bentley, P. and Fegan, C. (2003) "The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro", Blood, 101, 2454–2460.
   PubMed Web of Science ®Google Scholar